Sri Lanka
Sri Lanka
Explore linked clinical trials.33 results · Page 1 of 2
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Anuradhapura | Anuradhapura | Sri Lanka | 2 |
| Balapitiya | Balapitiya | Sri Lanka | 1 |
| Colombo | Colombo | Sri Lanka | 7 |
| Colombo | Colombo | Sri Lanka | 1 |
| Colombo | Colombo | Sri Lanka | 1 |
| Colombo | Colombo | Sri Lanka | 1 |
| Colombo | Colombo | Sri Lanka | 5 |
| Dehiwala | Dehiwala | Sri Lanka | 3 |
| Galle | Galle | Sri Lanka | 1 |
| Galle | Galle | Sri Lanka | 3 |
| Gampaha | Gampaha | Sri Lanka | 2 |
| Jaffna | Jaffna | Sri Lanka | 2 |
| Jaffna | Jaffna | Sri Lanka | 5 |
| Jaffna | Jaffna | Sri Lanka | 1 |
| Kalubowila | Kalubowila | Sri Lanka | 1 |
| Kandy | Kandy | Sri Lanka | 5 |
| Kandy | Kandy | Sri Lanka | 6 |
| Kandy | Kandy | Sri Lanka | 1 |
| Karapitiya | Karapitiya | Sri Lanka | 1 |
| Kelaniya | Kelaniya | Sri Lanka | 1 |
| Kurunegala | Kurunegala | Sri Lanka | 4 |
| Kurunegala | Kurunegala | Sri Lanka | 1 |
| Kurunegala | Kurunegala | Sri Lanka | 1 |
| Matara | Matara | Sri Lanka | 1 |
| Negombo | Negombo | Sri Lanka | 3 |
21 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HFrEF Polypill in Sri Lanka RCT | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-10-06 | NCT07569640 | |
| The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect | Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 3 | 2026-10-05 | NCT06058585 | |
| A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF) | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-09-10 | NCT06024746 | |
| A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-09-10 | NCT06008197 | |
| Administering Atropine Through Autoinjectors Within Ambulance Services for Poisoning Patients in Sri Lanka's North Central Province | Pesticide Poisoning | Not yet recruiting | Not stated | 2026-09-09 | NCT07581301 | |
| Skin Type Determination Using Image Artificial Intelligence | Skin and Connective Tissue Diseases, photosensitivity disease, skin disorder | Recruiting | Not stated | 2026-08-14 | NCT07765303 | |
| Study of WAL0921 in Patients With Glomerular Kidney Diseases | Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glomerulonephritis, immune system disorder, kidney disorder, minimal change disease, nephritis, nephrosis, primary focal segmental glomerulosclerosis, urinary system disorder | Recruiting | Phase 2 | 2026-08-03 | NCT06466135 | |
| TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): a Stepped-Wedge Cluster Randomized Trial | Lower Resp Tract Infection | Recruiting | Not applicable | 2026-07-23 | NCT06331364 | |
| Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Active, not recruiting | Phase 3 | 2026-07-14 | NCT05248646 | |
| A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-07-10 | NCT06033950 | |
| Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Enrolling by invitation | Phase 2 / Phase 3 | 2026-05-05 | NCT05248659 | |
| Physical Inactivity Among Patients With Cardiovascular Risk | Cardiovascular (CV) Risk; Empowerment; Physical Activities | Not yet recruiting | Not applicable | 2026-02-27 | NCT07440056 | |
| ICU-related Out of Pocket Expenses (ICOPE) | Cost of ICU; Out of Pocket Expenses | Recruiting | Not stated | 2026-02-27 | NCT07439692 | |
| Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 4 | 2026-01-22 | NCT05164263 | |
| Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, female infertility, female reproductive system disorder, infertility disorder | Recruiting | Not applicable | 2025-07-17 | NCT07066267 | |
| Clinical Trial on 7-day Followed by Maintenance Therapy for 10 Weeks vs. 14-day and no Maintenance Course of Prednisolone for the Treatment of Infantile Epileptic Spasms Syndrome (IESS) | Disease Attributes, Epilepsy, Generalized, Epileptic Syndromes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Spasms, Infantile, brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Active, not recruiting | Phase 4 | 2025-02-24 | NCT06838559 | |
| Comparing Efficacy of Dry Needling Combined with Passive Stretching and Muscle Energy Technique on Myofascial Trigger Points | Neck Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not applicable | 2025-01-17 | NCT06780904 | |
| SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 3 | 2024-12-20 | NCT05345327 | |
| Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Not stated | 2024-12-12 | NCT03138941 | |
| Testing and Comparing the Impacts of Mhealth-Based and Web-Based Education on Oral Cancer | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Stomatognathic Diseases, Tooth, Impacted, mouth disorder, neoplasm, tooth disorder | Not yet recruiting | Not applicable | 2024-12-02 | NCT06711848 | |
| Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Encephalopathy, Infant, Newborn, Diseases, brain disorder, central nervous system disorder, nervous system disorder, perinatal asphyxia | Recruiting | Phase 3 | 2024-03-19 | NCT05395195 |